Beyond Infection: How Antimicrobial Therapies Influence the Urinary Microbiome and Stone Disease
Pharmaceuticals · 12.07.2025 · 18 (7) · 1038
DOI: 10.3390/ph18071038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 12.07.2025. Verfasst von Oana Nicu-Canareica und 7 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program Studies, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The discovery of a resident urinary microbiome has significantly altered the understanding of urolithiasis, expanding its etiology beyond metabolic and dietary factors to include microbial contributions. This review highlights how specific uropathogens—particularly Proteus mirabilis, Klebsiella pneumoniae, and Escherichia coli—facilitate stone formation through mechanisms such as urease activity, citrate degradation, urine alkalinization, biofilm development, and inflammatory signaling. We critically examine how antibiotic therapies, while essential for treating urinary tract infections (UTIs), disrupt microbial homeostasis by depleting beneficial taxa like Lactobacillus and enabling colonization by lithogenic and resistant strains. Recurrent or broad-spectrum antibiotic use is linked to persistent dysbiosis and increased risk of stone recurrence. Additionally, this paper explores emerging microbiome-targeted strategies—such as probiotics, prebiotics, bacteriotherapy, and precision antimicrobials—as potential interventions to restore microbial balance and mitigate stone risk. Recognizing the urinary microbiome as a therapeutic target opens new avenues for personalized, microbiota-conscious strategies in the prevention and management of kidney stone disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral Program Studies, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
- Department of Fundamental Sciences, Faculty of Midwifery and Nursing, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
- Department of Clinical Laboratory of Radiology and Medical Imaging, Clinical Hospital "Prof. Dr. Theodor Burghele", 050664 Bucharest, Romania.
- Clinical Laboratory of Medical Microbiology, Marius Nasta Institute of Pneumology, 050159 Bucharest, Romania.
- Discipline of Public Health and Management, Department of Specific Sciences, Faculty of Midwifery and Nursing, University of Medicine and Pharmacy "Carol Davila", 050474 Bucharest, Romania.
- Genetics Department, Faculty of Biology, University of Bucharest, 060101 Bucharest, Romania.
ORCID-Profile: Loredana Sabina Cornelia Manolescu, Cosmin Medar, Liliana Burlibașa, Viorel Jinga
Zitieren
APA
Nicu-Canareica, O., Bolocan, V. O., Manolescu, L. S. C., Armean, P., Medar, C., Burlibașa, L., Băean, M. L., & Jinga, V. (2025). Beyond Infection: How Antimicrobial Therapies Influence the Urinary Microbiome and Stone Disease. Pharmaceuticals, 18(7), 1038. https://doi.org/10.3390/ph18071038
Vancouver
Nicu-Canareica O, Bolocan VO, Manolescu LSC, Armean P, Medar C, Burlibașa L, et al. Beyond Infection: How Antimicrobial Therapies Influence the Urinary Microbiome and Stone Disease. Pharmaceuticals. 2025;18(7):1038. doi:10.3390/ph18071038
BibTeX
@article{NicuCanareica2025,
author = {Nicu-Canareica, Oana and Bolocan, Vlad-Octavian and Manolescu, Loredana Sabina Cornelia and Armean, Petru and Medar, Cosmin and Burlibașa, Liliana and Băean, Maria-Luiza and Jinga, Viorel},
title = {Beyond Infection: How Antimicrobial Therapies Influence the Urinary Microbiome and Stone Disease},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {7},
pages = {1038},
doi = {10.3390/ph18071038}
}
EUVIMED